Market Survey on Fungal Testing Kits Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Fungal Testing Kits Market including Molecular Test and Chromogenic Test Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
The fungal testing kits market poised to increase exponentially, surpassing US$ 4504 million by 2033, from a predicted market size of US$ 1.72 billion in 2023.
The ensuing fungal testing kits market propulsion is due to increased acceptance of point-of-care diagnostics, the emergence of nano sensor detection based kits and fungal identification by molecular tools.
FMI presented a comparative analysis of market growth rates and development possibilities in the global fungal testing equipment market. Device restrictions, illness epidemiology, and the rate of product uptake all have an impact on the market, as do macroeconomic and industrial factors.
The creation of low-cost kits, as well as increased attempts to raise awareness of fungal diseases, is a significant step towards strengthening fungal testing kits industry.
Attributes
Details
Fungal Testing Kits Market HCAGR (From 2018 to 2022)
8.6%
Fungal Testing Kits Market CAGR (From 2023 to 2033)
10.1%
Fungal Testing Kits Market Size (2022)
US$ 1558 million
Fungal Testing Kits Market Size (2023)
US$ 1716.5 million
Fungal Testing Kits Market Size (2033)
US$ 4504.0 million
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Fungal Testing Kit Sales Analysis from 2018 to 2022 Compared to the Market Outlook from 2023 to 2033
From 2018 to 2022, the fungal testing equipment market grew at a CAGR of 8.6%, reaching US$ 1558 million in that year.
One of the few significant gynaecological issues affecting women of reproductive age is the rising occurrence of fungal illnesses such vaginitis. Vaginitis is becoming more common as a result of changing lifestyles, acquiring bad habits including smoking, and unprotected sexual activity.
These elements contribute to the increased demand for fungus testing kits on a global scale, particularly given the slow growth of anti-fungal studies and product development breakthroughs. The development of fungal testing kits for a variety of illness indications has been fueled by rising regional government financing initiatives for disease diagnosis and medical testing kit development.
Pharmaceutical companies are investing more in research to create novel antifungal diagnostics and treatments, and the key manufacturers are concentrating on teaming up with academic institutions or research institutes to create unique products.
Several potential treatments for fungi infections have also been investigated by researchers, including the use of bacteriophages and antifungal peptides. These methods are currently being developed, albeit they have not yet been successfully incorporated into medical products. In addition, it is anticipated that the prevalence of fungal diseases, which are brought on by the presence of fungus or mould, may increase.
A significant element that may spur fungal testing equipment market expansion is the commercial availability of enhanced diagnostic testing for fungi illnesses.
Profound Motivators
Increasing elderly population and susceptibility to fungal infections has seen enormous multiplication, resulting in an amazing long-term increase in the market.
As the prevalence of various fungal illnesses rises and the commercial availability of diagnostic tests expands, the fungal testing equipment market may likely expand to greater echelons.
Health-Related Awareness Campaigns Encourage Use of Testing Facilities Boosting Income
Healthcare providers and health organizations have launched a numerous awareness campaigns, including online education programs for the general public and medical professionals around the world as well as environmental campaigns, medication maintenance campaigns, and campaigns focusing on specific viral and fungus diseases.
These initiatives promote the use of testing facilities, which is likely to increase revenue for the global fungus test kits market during the course of the projected period.
People now live longer thanks to improvements in diagnostic and treatment costs brought about by changes in healthcare systems in many nations, including the USA and Japan.
In light of the high frequency of viral and fungal illnesses, rising life expectancy is another important driver projected to drive growth in the global fungal test kits market. The elderly population is more prone to fungal diseases or the risk of fungal disease is increased.
The fungal testing equipment market to expand at a significant rate, with a CAGR of close to 10.1%. The aforementioned reasons contribute to the fungus testing kits market sales forecast and add value to the entire healthcare sector.
Find your sweet spots for generating winning opportunities in this market.
The Pertinent Opportunity for Fungal Testing Kit Manufacturers
In comparison to North America and Europe, the fungal testing kits sector is growing rapidly in various Asian countries, including Japan, India, and China. This is mostly owing to the existence of a significant patient (asthmatic) population in these areas, including youngsters and the elderly.
The sector is experiencing opportunistic expansion in the collaborative market space and is participating in the fungal testing kits market, with a greater emphasis on investing in Asia Pacific growing nations.
Due to increased healthcare expenditures and the presence of a big patient pool suffering from various fungal diseases such as candida and IFD, these countries provide a tremendous potential for various healthcare devices.
The development of PCR techniques has enabled scientists to find novel genes, gene expression, and genetic variation in an organism's tissues, allowing them to control the comparative analysis of illnesses and normal tissues, which raises demand for fungal testing kits.
Real-time PCR techniques are commonly utilized in research laboratories to detect the existence of mutant genes or the quantitative level of gene copy number in transformed cell lines.
Omron Healthcare, Inc. established a subsidiary in South Korea in January 2013 to offer medical products for personal and professional usage.
Focusing on these developing markets is therefore projected to help creators and suppliers of fungal testing kits achieve significant revenue and market share growth. Growing healthcare research and development spending and the adoption of molecular diagnostic testing provide remunerative opportunities for the growth of the fungal test kits market.
Constraints on Demand for Fungal Testing Kits
In low- and middle-income countries in particular, the low level of social acceptability of infections has resulted in patients seeking care from office-based healthcare facilities that make the claim to be able to treat the condition naturally using conventional drugs.
Sexually transmitted diseases and genital diseases are spread significantly by these societal variables. Unemployment, poverty, and social injustice are a few of the significant, widespread issues that are contributing factors in the fungal testing equipment market.
The treatment of genital disease is hampered by a lack of openness and diversity in sexual communication, and the population of those who are underserved who have STDs grows.
Sexually active women frequently experience vaginitis. In social networks like sex workers, where high-risk health behaviors are predominant, vaginitis disproportionately impacts excluded groups and people who belong to those networks. Sexually transmitted diseases pose a serious threat to both sex workers and the people they provide services to. Due to this social burden, dishonest practices and claims of expertise in the treatment of genital and sexually transmitted illnesses have increased.
Despite its affordability and accuracy in the diagnosis of viral infections, the limitations of PCR are a crucial factor to take into account. Real-time PCR requires more time to run (2–5 hours) than other procedures, and there is a significant danger of contamination while handling, particularly during the specimen preparation step.
Another downside of immunoassays in the fungal test kits market is the high expense of supplies and equipment, especially in environments with limited resources. This is because automated techniques tend to be more precise and sensitive.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Comparative View of Adjacent Fungal Testing Kits Market
Fungal Testing Kits Market:
Attributes
Fungal Testing Kits Market
CAGR (From 2023 to 2033)
10.1%
Market Value (2023)
US$ 1716.5 million
Growth Factor
Aged individuals are quite susceptible to fungus infections. This element has contributed to the market's growth.
Opportunity
Governments are making more investments in the production of fungus diagnostic kits. This may have a favourable impact on market expansion.
Key Trends
Increased population means a higher likelihood of illnesses spreading. This can spur market expansion.
Rapid Medical Diagnostic Kits Market:
Attributes
Rapid Medical Diagnostic Kits Market
CAGR (From 2023 to 2033)
3.4%
Market Value (2023)
US$ 15.26 billion
Growth Factor
Due to the growing need for and knowledge of rapid medical evaluation of chronic disorders, the industry to pick up steam.
Opportunity
Due to the rise in multidrug resistant bacterial diseases, there is going to be an increased demand for urgent medical assessment.
Key Trends
The demand for quick medical supplies is rising as a result of changing environmental conditions and expanding populations, which is promoting market growth.
Sepsis Diagnostics Market:
Attributes
Sepsis Diagnostics Market
CAGR (From 2023 to 2033)
9.6%
Market Value (2023)
US$ 739.23 million
Growth Factor
Sepsis is very common, and as awareness grows, it may considerably fuel market growth.
Opportunity
Market expansion is being facilitated by rising regulatory approval rates and the introduction of technologically sophisticated diagnostic technologies.
Key Trends
The release of increasingly sophisticated diagnostic solutions to support market expansion.
Segmentation Outlook
Which Fungal Test Kits Test Type Has Had Been Leading Market Growth?
Segment
Details
Top Test Type
Molecular Test
CAGR % 2017 to 2022
6.6%
CAGR % 2023 to End of Forecast(2033)
7.5%
By 2023, molecular testing expects to have a market share of over 31.5% and to have experienced profitable growth at a CAGR of 7.5%. The molecular tests, unlike conventional testing techniques, only identify the chemicals that are indicative of the presence of the organism and do not identify the living organisms linked to the disease indication.
This guarantees accurate pathogen diagnosis and subsequent treatment, supporting the global market expansion for fungal testing kits.
Which End User is Noteworthy in the Global Market?
Segment
Details
Top End User
Diagnostic Laboratory
CAGR % 2017 to 2022
7.2%
CAGR % 2023 to End of Forecast(2033)
7.4%
The estimation for the fungal test kits market share held by diagnostic laboratories over the predicted period is 42.4%.
The diagnostic laboratories hold a sizeable global market share for fungal testing kits due to the accessibility of mobile test kit units in point-of-care diagnostic settings, and they are anticipated to maintain stable growth throughout the course of the forecast period.
Which Sample Type is contributing to the Market Growth for Fungal Testing Kits?
Segment
Details
Segment Share
36.1%
Segment CAGR
12.6%
With a market share of more than 36.1% in 2023, Skin anticipates a lucrative increase at a CAGR of 12.6% until the conclusion of the projected period. The majority of people who are susceptible to fungal-related illnesses have yeast infections and superficial skin diseases.
Consequently, using a sample of the patient's skin can reveal the type of pathogen causing the ailment and help with therapy, which is what is driving the fungus testing kits market.
Which Application Can Fuel the Growth of the Fungal Testing Equipment Market?
Segment
Details
Segment Share
67.3%
Segment CAGR
11%
Medical Diagnosis anticipates a profitable growth rate of 11.0% until the conclusion of the projected period, with a fungal test kits market share of more than 67.3% in 2023. The precise assessment of disease features in the diagnosis of fungal infections is a crucial part of disease organism elimination or control.
Medical diagnosis and tests are designed to provide precise insights into patients' infections and disorders, as well as accurate identification of the pathogen in question, resulting in better clinical outcomes.
Regional Outlook
Country
United States
HCAGR (2018-2022)
8.3%
CAGR (2023-2033)
9.8%
Country
China
HCAGR (2018-2022)
11.1%
CAGR (2023-2033)
12.9%
Country
Canada
HCAGR (2018-2022)
8.0%
CAGR (2023-2033)
8.4%
Country
Germany
HCAGR (2018-2022)
9.2%
CAGR (2023-2033)
12.6%
Country
United Kingdom
HCAGR (2018-2022)
9.5%
CAGR (2023-2033)
9.8%
What Creates the United States a Prominent Market?
Attributes
Details
United States Market Size (US$ million) by End of Forecast Period (2033)
US$ 1210.95 million
United States Market Absolute Dollar Growth (US$ million)
US$ 51.7 million
With a CAGR of 9.8%, the United States currently dominates the North American area, and it is anticipated that it may maintain its rapid growth during the forecast period. Due to the high prevalence of infectious diseases and the rapid advancements in diagnostic procedures, the nation has a sizable market share in the North American continent.
Throughout the anticipated time frame, the fungal test kits market to rise at a profitable rate owing to the essential presence of point-of-care diagnostics and education initiatives about infection prevention and control.
What Makes China a Hotspot for Fungal Testing Kits?
Attributes
Details
China Market Size (US$ million) by End of Forecast Period (2033)
US$ 488.22 million
China Market Absolute Dollar Growth (US$ million)
US$ 20.7 million
China is expected to represent 51.3% of the East Asia market in 2023, with a CAGR of 12.9% during the forecast period. The region of East Asia has an edge in terms of sales growth potential of fungal testing kits, attributable to a booming patient pool as well as the consequent expanding healthcare expenditure by the government agencies.
According to a national assessment on fungal infection diagnostic capacity in China, the overall testing capacity for fungal infections in China is limited, posing a significant opportunity for the country's fungal testing kits market to grow throughout the projection period.
Why is the Demand for Fungus Testing Kits Soaring in Canada?
Attributes
Details
Canada Market Size (US$ million) by End of Forecast Period (2033)
US$ 105.55 million
Canada Market Absolute Dollar Growth (US$ million)
US$ 4.00 million
Canadian market is escalating at a robust CAGR of 8.4% from 2023 to 2033 and attaining US$ 105.55 million by 2033.
In the North America area, Canada has grown into the second leading force in the fungal testing equipment market after the United States. This is due to the widespread incidence of infectious diseases. As knowledge of numerous fungal infections has grown in this region, the demand for fungal testing kits has increased.
Why is Germany Seen as a Lucrative Market in Europe for Fungus Testing Kits?
Attributes
Details
Germany Market Size (US$ million) by End of Forecast Period (2033)
US$ 352.17 million
Germany Market Absolute Dollar Growth (US$ million)
US$ 12.6 million
Germany is to experience a CAGR of roughly 12.6% in the European fungal testing kits market over the anticipated period. The established regulatory presence of medical and diagnostic items in the European region positions a higher presence of fungal testing kits in the nation.
A push into the sales of fungus testing kits in the nation has been further begun with the approval of such items and the existence of a CE mark. Furthermore, the region now presents a profitable value in terms of sales in Germany thanks to educational initiatives and awareness efforts.
Why Do Fungal Testing Kit Suppliers See the United Kingdom as a Key Market?
Attributes
Details
United Kingdom Market Size (US$ million) by End of Forecast Period (2033)
US$ 250.61 million
United Kingdom Market Absolute Dollar Growth (US$ million)
US$ 10.7 million
The United Kingdom market has the potential to approach US$ 250.61 million by 2033, with a CAGR of 19.8% from 2021 to 2031.
In light of the rising prevalence of cancer, rising fungal test kits manufacturers’ actions, and rising government initiatives, the usage of infectious disease diagnostics kits, assays, and other consumables has expanded.
The expanding usage of infectious disease diagnostics kits, tubes, and reagents among major end users, as well as increasing investments by healthcare businesses to meet industry demand, are likely to fuel fungal test kits market expansion.
What is the Future of Fungal Testing Kits in India?
Attributes
Details
India Market CAGR
14.5%
Indian Market Share
54.6%
In 2023, India held a 54.6% share in the South Asia fungal testing kits market, and is predicted to develop at a CAGR of 14.5% from 2023 to 2033. The pandemic caused a continuous increase in fungal diseases across India.
Medical diagnostic kit sales in the country increased with the help of internationally recognised players such as Abbott. Rising fungal testing kits sales to continue in the country, along with healthcare initiatives to ensure excellent patient outcomes.
How Competition Influences the Fungal Testing Kits Market?
In addition to focusing on research and development, leading fungal testing kits manufacturers prioritise the creation of new product lines with novel applications. To maintain their market presence, the leading firms also engage in mergers and acquisitions.
Recent Development
Date
March 2020
Company
BioMérieux
Details
The SARS-COV-2 R-GENE® test was developed by BioMérieux. The French Reference Center for Respiratory Infectious Diseases validated this real-time PCR test running on open platforms, showing its remarkable performance. It is manufactured and sold in France, and it is expected to be CE-marked and submitted to the FDA for a EUA (Emergency Use Authorization) soon. BioMérieux is also working on an improved version of their BIOFIRE® FILMARRAY® Respiratory Panel 2, dubbed the BIOFIRE® Respiratory Panel 2.1. (RP2.1). This new panel can include SARS-CoV-2 as well as 21 other prevalent respiratory viruses and can provide results in about 45 minutes. It can also be offered on the platforms FILMARRAY® 2.0 and FILMARRAY® TORCH.
Date
July 14, 2021
Company
ELITech Group
Details
Gonotec GmbH, a medical products company, was bought by ELITech Group.
Key Players
Biomed Diagnostics, Inc.
Bioquochem
C.P.M. Diagnostic Research SAS
ELITech Group
ADT Biotech
Cole-Parmer India Pvt. Ltd.
PerkinElmer
GenMark Diagnostics, Inc.
Norgen Biotek
PCRmax
Merck KGaA
Thermofisher Scientfic
Key Segments
By Test Type:
Molecular Test
Chromogenic Test
Others
By Sample Type:
Skin
Urine
Vaginal secretions
Blood
Cerebral
Others
By Application:
Research
Susceptibility Testing
Medical Diagnosis
Others
By End User:
Diagnostic Laboratory
Hospitals
Pharmaceutical Companies
Research and Academic Institutes
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Frequently Asked Questions
The global industry is expected to reach a valuation of US$ 1716.5 million in 2023.
the leading players in the Biomed Diagnostics, Inc., Bioquochem and C.P.M. Diagnostic Research SAS are the leading the industry players.
The fungal testing kits industry is likely to reach a valuation of US$ 4504.0 million by 2033.
Growing adoption of point-of-care diagnostics will drive industry sales.
The molecular test segment to remain preferred test type through 2033.
Table of Content
1. Executive Summary | Fungal Testing Kits Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033
5.3.1. Molecular Test
5.3.2. Chromogenic Test
5.3.3. Others
5.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Sample Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Sample Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033
6.3.1. Skin
6.3.2. Urine
6.3.3. Vaginal secretions
6.3.4. Blood
6.3.5. Cerebral
6.3.6. Others
6.4. Y-o-Y Growth Trend Analysis By Sample Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Sample Type, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Application , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application , 2023 to 2033
7.3.1. Research
7.3.2. Susceptibility Testing
7.3.3. Medical Diagnosis
7.3.4. Others
7.4. Y-o-Y Growth Trend Analysis By Application , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Application , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Diagnostic Laboratory
8.3.2. Hospitals
8.3.3. Pharmaceutical Companies
8.3.4. Research and Academic Institutes
8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Test Type
10.2.3. By Sample Type
10.2.4. By Application
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test Type
10.3.3. By Sample Type
10.3.4. By Application
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Test Type
11.2.3. By Sample Type
11.2.4. By Application
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Test Type
11.3.3. By Sample Type
11.3.4. By Application
11.3.5. By End User
11.4. Key Takeaways
12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. United kingdom
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Test Type
12.2.3. By Sample Type
12.2.4. By Application
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Test Type
12.3.3. By Sample Type
12.3.4. By Application
12.3.5. By End User
12.4. Key Takeaways
13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Malaysia
13.2.1.3. Singapore
13.2.1.4. Thailand
13.2.1.5. Rest of South Asia
13.2.2. By Test Type
13.2.3. By Sample Type
13.2.4. By Application
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Test Type
13.3.3. By Sample Type
13.3.4. By Application
13.3.5. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Test Type
14.2.3. By Sample Type
14.2.4. By Application
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Test Type
14.3.3. By Sample Type
14.3.4. By Application
14.3.5. By End User
14.4. Key Takeaways
15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. Australia
15.2.1.2. New Zealand
15.2.2. By Test Type
15.2.3. By Sample Type
15.2.4. By Application
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Test Type
15.3.3. By Sample Type
15.3.4. By Application
15.3.5. By End User
15.4. Key Takeaways
16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Test Type
16.2.3. By Sample Type
16.2.4. By Application
16.2.5. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Test Type
16.3.3. By Sample Type
16.3.4. By Application
16.3.5. By End User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Test Type
17.1.2.2. By Sample Type
17.1.2.3. By Application
17.1.2.4. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Test Type
17.2.2.2. By Sample Type
17.2.2.3. By Application
17.2.2.4. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Test Type
17.3.2.2. By Sample Type
17.3.2.3. By Application
17.3.2.4. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Test Type
17.4.2.2. By Sample Type
17.4.2.3. By Application
17.4.2.4. By End User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Test Type
17.5.2.2. By Sample Type
17.5.2.3. By Application
17.5.2.4. By End User
17.6. United kingdom
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Test Type
17.6.2.2. By Sample Type
17.6.2.3. By Application
17.6.2.4. By End User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Test Type
17.7.2.2. By Sample Type
17.7.2.3. By Application
17.7.2.4. By End User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Test Type
17.8.2.2. By Sample Type
17.8.2.3. By Application
17.8.2.4. By End User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Test Type
17.9.2.2. By Sample Type
17.9.2.3. By Application
17.9.2.4. By End User
17.10. India
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Test Type
17.10.2.2. By Sample Type
17.10.2.3. By Application
17.10.2.4. By End User
17.11. Malaysia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Test Type
17.11.2.2. By Sample Type
17.11.2.3. By Application
17.11.2.4. By End User
17.12. Singapore
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Test Type
17.12.2.2. By Sample Type
17.12.2.3. By Application
17.12.2.4. By End User
17.13. Thailand
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Test Type
17.13.2.2. By Sample Type
17.13.2.3. By Application
17.13.2.4. By End User
17.14. China
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Test Type
17.14.2.2. By Sample Type
17.14.2.3. By Application
17.14.2.4. By End User
17.15. Japan
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Test Type
17.15.2.2. By Sample Type
17.15.2.3. By Application
17.15.2.4. By End User
17.16. South Korea
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Test Type
17.16.2.2. By Sample Type
17.16.2.3. By Application
17.16.2.4. By End User
17.17. Australia
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Test Type
17.17.2.2. By Sample Type
17.17.2.3. By Application
17.17.2.4. By End User
17.18. New Zealand
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Test Type
17.18.2.2. By Sample Type
17.18.2.3. By Application
17.18.2.4. By End User
17.19. GCC Countries
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Test Type
17.19.2.2. By Sample Type
17.19.2.3. By Application
17.19.2.4. By End User
17.20. South Africa
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Test Type
17.20.2.2. By Sample Type
17.20.2.3. By Application
17.20.2.4. By End User
17.21. Israel
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Test Type
17.21.2.2. By Sample Type
17.21.2.3. By Application
17.21.2.4. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Test Type
18.3.3. By Sample Type
18.3.4. By Application
18.3.5. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Biomed Diagnostics, Inc.
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Bioquochem
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. C.P.M. Diagnostic Research SAS
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. ELITech Group
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. ADT Biotech
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Cole-Parmer India Pvt. Ltd.
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. PerkinElmer
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. GenMark Diagnostics, Inc.
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. Norgen Biotek
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. PCRmax
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.11. Merck KGaA
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.12. Thermofisher Scientfic
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
20. Assumptions & Acronyms Used21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033
Table 4: Global Market Value (US$ Million) Forecast by Application , 2018 to 2033
Table 5: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 8: North America Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033
Table 9: North America Market Value (US$ Million) Forecast by Application , 2018 to 2033
Table 10: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 13: Latin America Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033
Table 14: Latin America Market Value (US$ Million) Forecast by Application , 2018 to 2033
Table 15: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 16: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 17: Europe Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 18: Europe Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033
Table 19: Europe Market Value (US$ Million) Forecast by Application , 2018 to 2033
Table 20: Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 21: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: South Asia Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 23: South Asia Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033
Table 24: South Asia Market Value (US$ Million) Forecast by Application , 2018 to 2033
Table 25: South Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 26: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 27: East Asia Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 28: East Asia Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033
Table 29: East Asia Market Value (US$ Million) Forecast by Application , 2018 to 2033
Table 30: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 31: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 32: Oceania Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 33: Oceania Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033
Table 34: Oceania Market Value (US$ Million) Forecast by Application , 2018 to 2033
Table 35: Oceania Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 36: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 37: MEA Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 38: MEA Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033
Table 39: MEA Market Value (US$ Million) Forecast by Application , 2018 to 2033
Table 40: MEA Market Value (US$ Million) Forecast by End User, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Sample Type, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Application , 2023 to 2033
Figure 4: Global Market Value (US$ Million) by End User, 2023 to 2033
Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 6: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 9: Global Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 10: Global Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 11: Global Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 12: Global Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033
Figure 13: Global Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033
Figure 14: Global Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033
Figure 15: Global Market Value (US$ Million) Analysis by Application , 2018 to 2033
Figure 16: Global Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 17: Global Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 18: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 21: Global Market Attractiveness by Test Type, 2023 to 2033
Figure 22: Global Market Attractiveness by Sample Type, 2023 to 2033
Figure 23: Global Market Attractiveness by Application , 2023 to 2033
Figure 24: Global Market Attractiveness by End User, 2023 to 2033
Figure 25: Global Market Attractiveness by Region, 2023 to 2033
Figure 26: North America Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 27: North America Market Value (US$ Million) by Sample Type, 2023 to 2033
Figure 28: North America Market Value (US$ Million) by Application , 2023 to 2033
Figure 29: North America Market Value (US$ Million) by End User, 2023 to 2033
Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 37: North America Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033
Figure 38: North America Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033
Figure 39: North America Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033
Figure 40: North America Market Value (US$ Million) Analysis by Application , 2018 to 2033
Figure 41: North America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 42: North America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 43: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 46: North America Market Attractiveness by Test Type, 2023 to 2033
Figure 47: North America Market Attractiveness by Sample Type, 2023 to 2033
Figure 48: North America Market Attractiveness by Application , 2023 to 2033
Figure 49: North America Market Attractiveness by End User, 2023 to 2033
Figure 50: North America Market Attractiveness by Country, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 52: Latin America Market Value (US$ Million) by Sample Type, 2023 to 2033
Figure 53: Latin America Market Value (US$ Million) by Application , 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) by End User, 2023 to 2033
Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 59: Latin America Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 62: Latin America Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033
Figure 65: Latin America Market Value (US$ Million) Analysis by Application , 2018 to 2033
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 68: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 71: Latin America Market Attractiveness by Test Type, 2023 to 2033
Figure 72: Latin America Market Attractiveness by Sample Type, 2023 to 2033
Figure 73: Latin America Market Attractiveness by Application , 2023 to 2033
Figure 74: Latin America Market Attractiveness by End User, 2023 to 2033
Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 76: Europe Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 77: Europe Market Value (US$ Million) by Sample Type, 2023 to 2033
Figure 78: Europe Market Value (US$ Million) by Application , 2023 to 2033
Figure 79: Europe Market Value (US$ Million) by End User, 2023 to 2033
Figure 80: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 84: Europe Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 85: Europe Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 87: Europe Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033
Figure 88: Europe Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033
Figure 90: Europe Market Value (US$ Million) Analysis by Application , 2018 to 2033
Figure 91: Europe Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 93: Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 96: Europe Market Attractiveness by Test Type, 2023 to 2033
Figure 97: Europe Market Attractiveness by Sample Type, 2023 to 2033
Figure 98: Europe Market Attractiveness by Application , 2023 to 2033
Figure 99: Europe Market Attractiveness by End User, 2023 to 2033
Figure 100: Europe Market Attractiveness by Country, 2023 to 2033
Figure 101: South Asia Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 102: South Asia Market Value (US$ Million) by Sample Type, 2023 to 2033
Figure 103: South Asia Market Value (US$ Million) by Application , 2023 to 2033
Figure 104: South Asia Market Value (US$ Million) by End User, 2023 to 2033
Figure 105: South Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 106: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 107: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 108: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 109: South Asia Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 110: South Asia Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 111: South Asia Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 112: South Asia Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033
Figure 113: South Asia Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033
Figure 114: South Asia Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033
Figure 115: South Asia Market Value (US$ Million) Analysis by Application , 2018 to 2033
Figure 116: South Asia Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 117: South Asia Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 118: South Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 119: South Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 120: South Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 121: South Asia Market Attractiveness by Test Type, 2023 to 2033
Figure 122: South Asia Market Attractiveness by Sample Type, 2023 to 2033
Figure 123: South Asia Market Attractiveness by Application , 2023 to 2033
Figure 124: South Asia Market Attractiveness by End User, 2023 to 2033
Figure 125: South Asia Market Attractiveness by Country, 2023 to 2033
Figure 126: East Asia Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 127: East Asia Market Value (US$ Million) by Sample Type, 2023 to 2033
Figure 128: East Asia Market Value (US$ Million) by Application , 2023 to 2033
Figure 129: East Asia Market Value (US$ Million) by End User, 2023 to 2033
Figure 130: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 131: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 134: East Asia Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 135: East Asia Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 137: East Asia Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033
Figure 138: East Asia Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033
Figure 139: East Asia Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033
Figure 140: East Asia Market Value (US$ Million) Analysis by Application , 2018 to 2033
Figure 141: East Asia Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 142: East Asia Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 143: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 144: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 145: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 146: East Asia Market Attractiveness by Test Type, 2023 to 2033
Figure 147: East Asia Market Attractiveness by Sample Type, 2023 to 2033
Figure 148: East Asia Market Attractiveness by Application , 2023 to 2033
Figure 149: East Asia Market Attractiveness by End User, 2023 to 2033
Figure 150: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 151: Oceania Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 152: Oceania Market Value (US$ Million) by Sample Type, 2023 to 2033
Figure 153: Oceania Market Value (US$ Million) by Application , 2023 to 2033
Figure 154: Oceania Market Value (US$ Million) by End User, 2023 to 2033
Figure 155: Oceania Market Value (US$ Million) by Country, 2023 to 2033
Figure 156: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 157: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 158: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 159: Oceania Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 160: Oceania Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 161: Oceania Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 162: Oceania Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033
Figure 163: Oceania Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033
Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033
Figure 165: Oceania Market Value (US$ Million) Analysis by Application , 2018 to 2033
Figure 166: Oceania Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 167: Oceania Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 168: Oceania Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 169: Oceania Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 170: Oceania Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 171: Oceania Market Attractiveness by Test Type, 2023 to 2033
Figure 172: Oceania Market Attractiveness by Sample Type, 2023 to 2033
Figure 173: Oceania Market Attractiveness by Application , 2023 to 2033
Figure 174: Oceania Market Attractiveness by End User, 2023 to 2033
Figure 175: Oceania Market Attractiveness by Country, 2023 to 2033
Figure 176: MEA Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 177: MEA Market Value (US$ Million) by Sample Type, 2023 to 2033
Figure 178: MEA Market Value (US$ Million) by Application , 2023 to 2033
Figure 179: MEA Market Value (US$ Million) by End User, 2023 to 2033
Figure 180: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 181: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 184: MEA Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 185: MEA Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 186: MEA Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 187: MEA Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033
Figure 188: MEA Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033
Figure 189: MEA Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033
Figure 190: MEA Market Value (US$ Million) Analysis by Application , 2018 to 2033
Figure 191: MEA Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 192: MEA Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 193: MEA Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 194: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 195: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 196: MEA Market Attractiveness by Test Type, 2023 to 2033
Figure 197: MEA Market Attractiveness by Sample Type, 2023 to 2033
Figure 198: MEA Market Attractiveness by Application , 2023 to 2033
Figure 199: MEA Market Attractiveness by End User, 2023 to 2033
Figure 200: MEA Market Attractiveness by Country, 2023 to 2033
